|
|
Volumn 143, Issue 8, 2005, Pages
|
|
The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIINFLAMMATORY AGENT;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
CHEMICALLY INDUCED DISORDER;
DRUG INTERACTION;
HEART INFARCTION;
HUMAN;
NOTE;
RISK FACTOR;
ANTI-INFLAMMATORY AGENTS;
ASPIRIN;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG INTERACTIONS;
HUMANS;
MEMBRANE PROTEINS;
MYOCARDIAL INFARCTION;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 26944470838
PISSN: None
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-143-8-200510180-00022 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
